Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026

BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 16, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the first quarter 2026 on Thursday, May 7, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, […]

Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting

BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 15, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that there will be two customer posters presented at the American Association of Cancer Research (AACR) annual meeting on April 17-22, 2026 in San Diego, California. Poster 2421; April […]

Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies

BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 14, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a new manuscript available via pre-print on bioRxiv from researchers out of the University of British Columbia and the B.C. Cancer Research Institute. In the pre-print titled “Heterologous expression […]

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 10, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 61,439 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity […]

Quantum-Si Announces First Customer Samples Tested on the Proteus™ Prototype System

Sequencing Results Utilizing a Proteus Prototype System Exceeds Platinum® Pro BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 8, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced that the Company has completed the sequencing of multiple samples provided by an existing Platinum Pro customer on […]

Quantum-Si Announces the Start of the Proteus™ Roadshow

Multi-city Roadshow To Drive Awareness of Proteus and Develop Customer Funnel for Commercial Launch BRANFORD, Conn.–(BUSINESS WIRE)–Apr. 6, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the start of a roadshow designed to accelerate the education of the market on its […]

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRANFORD, Conn.–(BUSINESS WIRE)–Mar. 13, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 88,781 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity […]

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 13, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 52,296 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity […]

Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 10, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the fourth quarter and full year 2025 on Tuesday, March 3, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, […]

Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection

BRANFORD, Conn.–(BUSINESS WIRE)–Feb. 5, 2026– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced two new manuscripts have been released, one as a peer reviewed publication in the Journal of Analytical Chemistry and one via preprint on ChemRxiv. The preprint has also been […]